comparemela.com
Home
Live Updates
Quell Therapeutics Advances QEL-001, Its Multi-Modular Engin
Quell Therapeutics Advances QEL-001, Its Multi-Modular Engin
Quell Therapeutics Advances QEL-001, Its Multi-Modular Engineered CAR-Treg Cell Therapy, Into Efficacy Cohort Of LIBERATE Phase 1/2 Trial In Liver Tra...
Progress in the LIBERATE trial was presented at the American Transplant
Related Keywords
Fueyo ,
Asturias ,
Spain ,
United States ,
Belgium ,
United Kingdom ,
London ,
City Of ,
Philadelphia ,
Pennsylvania ,
American ,
Luke Devey ,
Frazer Hall ,
Corey Davis ,
Sandi Greenwood ,
Luke Henry ,
Astrazeneca ,
American Transplant Congress ,
Therapeutics Ltd ,
American Transplant ,
Quell Therapeutics Ltd ,
Data Safety ,
Monitoring Board ,
Academic Director ,
Liver Studies ,
Kings College London ,
Chief Medical Officer ,
Quell Therapeutics ,
Chief Business ,
Mark Swallow ,